Role of the cyclic-AMP/PKA cascade and of P/Q-type Ca++ channels in endocannabinoid-mediated long-term depression in the nucleus accumbens
Abstract
Glutamate transmission between prefrontal cortex (PFC) and accumbens (NAc) plays a crucial role in the establishment and expression of addictive behaviors. At these synapses exogenous cannabinoid receptor 1 (CB1R) agonists reversibly inhibit excitatory transmission, and the sustained release of endogenous cannabinoids (eCB) following prolonged cortical stimulation leads to long-term depression (LTD). Activation of presynaptic K(+) channels mediates the effects of exocannabinoids, but the transduction pathway underlying the protracted phase of eCB-LTD is unknown. Here we report that the maintenance of eCB-LTD does not involve presynaptic K(+) channels: eCB-LTD was not affected by blockade of K(+) channels with 4-AP (100 microM) and BaCl(2) (300 microM) (fEPSP=78.9+/-5.4% of baseline 58-60 min after tetanus, compared to 78.9+/-5.9% in control slices). In contrast, eCB-LTD was blocked by treatment of the slices with the adenylyl cyclase (AC) activator forskolin (10 microM), and with the protein kinase A (PKA) inhibitor KT5720 (1 microM) (fEPSP=108.9+/-5.7% in forskolin and 110.5+/-7.7% in KT5720, compared to 80.6+/-3.9% in control conditions). Additionally, selective blockade of P/Q-type Ca(2+) channels with omega-agatoxin-IVA (200 nM) occluded the expression of eCB-LTD (fEPSP=113.4+/-15.9% compared to 78.6+/-4.4% in control slices), while blockade of N- with omega-conotoxin-GVIA (1 microM) or L-type Ca(2+) channels with nimodipine (1 microM), was without effect (fEPSP was 83.7+/-5.3% and 87+/-8.9% respectively). These data show that protracted inhibition of AC/PKA activity and P/Q-type Ca(2+) channels are necessary for expression of eCB-LTD at NAc synapses.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
CB1R negatively regulates N- and P/Q-type voltage-gated calcium channels and positively regulates inwardly rectifying K+ channels, as well as calcineurin, to change the phosphorylation state of effector molecules.
“In addition, CB1R negatively regulates N- and P/Q-type voltage-gated calcium channels [26] and positively regulates inwardly rectifying K+ channels [26,27], as well as protein serine/threonine phosphatase 2B (calcineurin, PP2B) to change the phosphorylation state of various effector molecules [28,29].”
From Amygdala FAAH and anandamide: mediating protection and recovery from stress (2013) · cites this paper as [26]
Cites
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819 · see citing works
The Neural Basis of Addiction: A Pathology of Motivation and Choice
Kalivas, P. W., & Volkow, N. D. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.8.1403 · Cited by 2,757 · see citing works
Role for rapid dendritic protein synthesis in hippocampal mGluR-dependent long-term depression.
Huber, K., Kayser, M., & Bear, M. (2000) · Science · doi:10.1126/science.288.5469.1254 · Cited by 1,015 · see citing works
McFarland, K., Lapish, C. C., & Kalivas, P. W. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-08-03531.2003 · Cited by 884 · see citing works
Voltage-dependent modulation of N-type calcium channels by G-protein β γsubunits
Ikeda, S. R. (1996) · Nature · doi:10.1038/380255a0 · Cited by 837 · see citing works
Modulation of Ca2+ channels βγ G-protein py subunits
Herlitze, S., Garcı́a, D. E., Mackie, K., Hille, B., Scheuer, T., & Catterall, W. A. (1996) · Nature · doi:10.1038/380258a0 · Cited by 825 · see citing works
ENDOCANNABINOID-MEDIATED SYNAPTIC PLASTICITY IN THE CNS
Chevaleyre, V., Takahashi, K. A., & Castillo, P. E. (2006) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.29.051605.112834 · Cited by 779 · see citing works
Kelley, A. E. (2004) · Neuron · doi:10.1016/j.neuron.2004.09.016 · Cited by 773 · see citing works
Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens
Robbe, D., Köpf, M., Rémaury, A., Bockaert, J., & Manzoni, O. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122149199 · Cited by 631 · see citing works
Pierce, R. C., Bell, K., Duffy, P., & Kalivas, P. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-04-01550.1996 · Cited by 624 · see citing works
Glutamate Transmission in the Nucleus Accumbens Mediates Relapse in Cocaine Addiction
Cornish, J. L., & Kalivas, P. W. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-15-j0006.2000 · Cited by 546 · see citing works
Presynaptic Specificity of Endocannabinoid Signaling in the Hippocampus
Wilson, R. I., Kunos, G., & Nicoll, R. A. (2001) · Neuron · doi:10.1016/s0896-6273(01)00372-5 · Cited by 543 · see citing works
Howlett, A. C. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00060-6 · Cited by 536 · see citing works
A cannabinoid mechanism in relapse to cocaine seeking
Vries, T. J. D., Shaham, Y., Homberg, J. R., Crombag, H. S., Schuurman, K. G., Dieben, J., Vanderschuren, L. J. M. J., & Schoffelmeer, A. N. M. (2001) · Nature Medicine · doi:10.1038/nm1001-1151 · Cited by 433 · see citing works
Moran, M., McFarland, K., Meléndez, R. I., Kalivas, P. W., & Seamans, J. K. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.1007-05.2005 · Cited by 412 · see citing works
Mechanisms of Cannabinoid Inhibition of GABAASynaptic Transmission in the Hippocampus
Hoffman, A. F., & Lupica, C. R. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-07-02470.2000 · Cited by 401 · see citing works
Robbe, D., Alonso, G., Duchamp, F., Bockaert, J., & Manzoni, O. J. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-01-00109.2001 · Cited by 367 · see citing works
Kreitzer, A. C., & Malenka, R. C. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.2959-05.2005 · Cited by 358 · see citing works
Chavez-Noriega, L., & Stevens, C. F. (1994) · Journal of Neuroscience · doi:10.1523/jneurosci.14-01-00310.1994 · Cited by 300 · see citing works
Lupica, C. R., & Riegel, A. C. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.03.016 · Cited by 256 · see citing works
Trudeau, L., Emery, D. G., & Haydon, P. G. (1996) · Neuron · doi:10.1016/s0896-6273(00)80210-x · Cited by 228 · see citing works
A single in-vivo exposure to Δ9THC blocks endocannabinoid-mediated synaptic plasticity
Mato, S., Chevaleyre, V., Robbe, D., Pazos, Á., Castillo, P. E., & Manzoni, O. J. (2004) · Nature Neuroscience · doi:10.1038/nn1251 · Cited by 220 · see citing works
Fourgeaud, L., Mato, S., Bouchet, D., Hémar, A., Worley, P. F., & Manzoni, O. J. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.0671-04.2004 · Cited by 207 · see citing works
Modulation of Group II Metabotropic Glutamate Receptor Signaling by Chronic Cocaine
Xi, Z., Ramamoorthy, S., Baker, D. L., Shen, H., Samuvel, D. J., & Kalivas, P. W. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.039735 · Cited by 181 · see citing works
Synaptic Plasticity in an In Vitro Slice Preparation of the Rat Nucleus Accumbens
Pennartz, C. M. A., Ameerun, R. F., Groenewegen, H. J., & Lopes, F. H. D. S. (1993) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1993.tb00475.x · Cited by 178 · see citing works
A Role for cAMP in Long-Term Depression at Hippocampal Mossy Fiber Synapses
Tzounopoulos, T., Janz, R., Südhof, T. C., Nicoll, R. A., & Malenka, R. C. (1998) · Neuron · doi:10.1016/s0896-6273(00)80599-1 · Cited by 167 · see citing works
Xi, Z., Gilbert, J. G., Peng, X., Pak, A. C., Li, X., & Gardner, E. L. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0726-06.2006 · Cited by 162 · see citing works
Synaptic plasticity in the mesolimbic dopamine system
Thomas, M. J., & Malenka, R. C. (2003) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.2002.1236 · Cited by 137 · see citing works
Robbe, D., Alonso, G., Chaumont‐Dubel, S., Bockaert, J., & Manzoni, O. J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-11-04346.2002 · Cited by 124 · see citing works
Pelkey, K. A., Topolnik, L., Lacaille, J.-C., & McBain, C. J. (2006) · Neuron · doi:10.1016/j.neuron.2006.08.032 · Cited by 115 · see citing works
Huang, F.-S., Chotiner, J. K., & Steward, O. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.1779-05.2005 · Cited by 112 · see citing works
Visualization of Cyclic AMP–Regulated Presynaptic Activity at Cerebellar Granule Cells
Chavis, P., Mollard, P., Bockaert, J., & Manzoni, O. J. (1998) · Neuron · doi:10.1016/s0896-6273(00)81015-6 · Cited by 111 · see citing works
The Role of Protein Synthesis in Striatal Long-Term Depression
Yin, H. H., Davis, M. I., Ronesi, J. A., & Lovinger, D. M. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3196-06.2006 · Cited by 101 · see citing works
Mato, S., Robbe, D., Puente, N., Grandes, P., & Manzoni, O. J. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.2294-05.2005 · Cited by 97 · see citing works
Robbe, D., Bockaert, J., & Manzoni, O. J. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02273.x · Cited by 81 · see citing works
Bossert, J. M., Poles, G. C., Sheffler-Collins, S. I., & Ghitza, U. E. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.06.008 · Cited by 72 · see citing works
Huang, Y.-C., Wang, S., Chiou, L., & Gean, P. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-32-10311.2003 · Cited by 70 · see citing works
Inositol hexakisphosphate increases L‐type Ca 2+ channel activity by stimulation of adenylyl cyclase
Yang, S.-N., Yu, J. H., Mayr, G. W., Hofmann, F., Larsson, O., & Berggren, P. (2001) · The FASEB Journal · doi:10.1096/fj.00-0799com · Cited by 45 · see citing works
Selective Enhancement of P-Type Calcium Currents by Isoproterenol in the Rat Amygdala
Huang, C., Wang, S., & Gean, P. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-06-02276.1998 · Cited by 44 · see citing works
Arias‐Montaño, J., Florán, B., Florán, L., Aceves, J., & Young, J. M. (2007) · Synapse · doi:10.1002/syn.20372 · Cited by 41 · see citing works
Ghirardi, M., Benfenati, F., Giovedı̀, S., Fiumara, F., Milanese, C., & Montarolo, P. G. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.5671-03.2004 · Cited by 22 · see citing works
Cyclic AMP-dependent modulation of N- and Q-type Ca2+ channels expressed in Xenopus oocytes
Fukuda, K., Kaneko, S., Yada, N., Kikuwata, M., Akaike, A., & Satoh, M. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)13055-x · Cited by 21 · see citing works
Differential regulation of N- and Q-type Ca2+ channels by cyclic nucleotides and G-proteins
Kaneko, S., AKAIKE, A., & Satoh, M. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00104-0 · Cited by 18 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Endocannabinoid-Mediated Control of Synaptic Transmission
Kano, M., Ohno‐Shosaku, T., Hashimotodani, Y., Uchigashima, M., & Watanabe, M. (2009) · Physiological Reviews · doi:10.1152/physrev.00019.2008 · Cited by 1,529 · see citing works
Endocannabinoid Signaling and Synaptic Function
Castillo, P. E., Younts, T. J., Chávez, A. E., & Hashimotodani, Y. (2012) · Neuron · doi:10.1016/j.neuron.2012.09.020 · Cited by 1,126 · see citing works
“Moreover, dysregulation of the eCB system is implicated in neuropsychiatric conditions such as depression and anxiety (Hillard et al., 2012; Mechoulam and Parker, 2012).”
BackgroundScofield, M. D., Heinsbroek, J. A., Gipson, C. D., Kupchik, Y. M., Spencer, S., Smith, A. C. W., Roberts-Wolfe, D., & Kalivas, P. W. (2016) · Pharmacological Reviews · doi:10.1124/pr.116.012484 · Cited by 598 · see citing works
“…effect of cannabinoids on glutamate neurotransmission, tetanic electrical stimulation of NAc afferents (13 Hz for 10 minutes) induces LTD that depends on activation of CB1 receptors (eCB LTD) (Robbe et al., 2002c; Hoffman et al., 2003; Fourgeaud et al., 2004; Mato et al., 2004, 2005, 2008).”
BackgroundEndocannabinoid signaling as a synaptic circuit breaker in neurological disease
Katona, I., & Freund, T. F. (2008) · Nature Medicine · doi:10.1038/nm.f.1869 · Cited by 579 · see citing works
Endocannabinoid Signaling and Long-Term Synaptic Plasticity
Heifets, B. D., & Castillo, P. E. (2009) · Annual Review of Physiology · doi:10.1146/annurev.physiol.010908.163149 · Cited by 488 · see citing works
Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions
Lafourcade, M., Larrieu, T., Mato, S., Duffaud, A. M., Sepers, M. D., Matias, I., Smedt, V. D., Labrousse, V. F., Brétillon, L., Matute, C., et al. (2011) · Nature Neuroscience · doi:10.1038/nn.2736 · Cited by 314 · see citing works
Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome
Jung, K., Sepers, M. D., Henstridge, C. M., Lassalle, O., Neuhofer, D. N., Martin, H. G. S., Ginger, M. R., Frick, A., DiPatrizio, N. V., Mackie, K., et al. (2012) · Nature Communications · doi:10.1038/ncomms2045 · Cited by 282 · see citing works
Amygdala FAAH and anandamide: mediating protection and recovery from stress
Gunduz-Cinar, O., Hill, M. N., McEwen, B. S., & Holmes, A. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.08.008 · Cited by 229 · see citing works
“In addition, CB1R negatively regulates N- and P/Q-type voltage-gated calcium channels [26] and positively regulates inwardly rectifying K+ channels [26,27], as well as protein serine/threonine phosphatase 2B (calcineurin, PP2B) to change the phosphorylation state of various effector molecules [28,29].”
BackgroundEndocannabinoid modulation of dopamine neurotransmission
Covey, D., Mateo, Y., Sulzer, D., Cheer, J., & Lovinger, D. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.04.033 · Cited by 164 · see citing works
“, 2008) e and inhibition of AC by CB1-linked Gai/o signaling, leading to inhibition of protein kinase A and decreased phosphorylation of substrates such as the vesicleassociated Rim1 proteins (Chevaleyre et al., 2007; Mato et al., 2008).”
BackgroundInfluentialMonday, H. R., Younts, T. J., & Castillo, P. E. (2018) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-080317-062155 · Cited by 175 · see citing works
“A similar mechanism for preLTD in the nucleus accumbens (NAc) relies on presynaptic Gi/o-coupled cannabinoid-1 (CB1) and mGluR2/3 receptors signaling (Mato et al. 2008, Robbe et al. 2002).”
BackgroundPolymodal activation of the endocannabinoid system in the extended amygdala
Puente, N., Cui, Y., Lassalle, O., Lafourcade, M., Georges, F., Venance, L., Grandes, P., & Manzoni, O. J. (2011) · Nature Neuroscience · doi:10.1038/nn.2974 · Cited by 173 · see citing works
Presynaptic LTP and LTD of Excitatory and Inhibitory SynapsesPreprint
Castillo, P. E. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a005728 · Cited by 169 · see citing works
Patel, S., & Hillard, C. J. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06266.x · Cited by 162 · see citing works
Presynaptic long-term plasticity
Yang, Y., & Calakos, N. (2013) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2013.00008 · Cited by 135 · see citing works
Endocannabinoids in Synaptic Plasticity and Neuroprotection
Xu, J., & Chen, C. (2014) · The Neuroscientist · doi:10.1177/1073858414524632 · Cited by 138 · see citing works
Jung, K., Astarita, G., Yaşar, S., Vasilevko, V., Cribbs, D. H., Head, E., Cotman, C. W., & Piomelli, D. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.03.012 · Cited by 132 · see citing works
“They regulate synaptic plasticity in various regions of the brain through both short-term and long-term mechanisms, which include depolarization-induced suppression of inhibition at hippocampal GABAergic synapses and long-term depression at cortical or accumbal glutamatergic synapses (Hashimotodani, 2007; Chevaleyre e…”
BackgroundPan, B., Hillard, C., & Liu, Q.-S. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.4035-08.2008 · Cited by 112 · see citing works
“Recent studies have shown that cAMP/PKA signaling is required for eCB-mediated LTD in the striatum and I-LTD in the hippocampus (Chevaleyre et al., 2007; Mato et al., 2008).”
BackgroundSynaptic plasticity in the basal ganglia
Wickens, J. R. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.10.030 · Cited by 113 · see citing works
Presynaptic long-term depression mediated by Gi/o-coupled receptors
Atwood, B. K., Lovinger, D. M., & Mathur, B. N. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2014.07.010 · Cited by 107 · see citing works
Mateo, Y., Johnson, K. A., Covey, D. P., Atwood, B. K., Wang, H., Zhang, S., Gildish, I., Cachope, R., Bellocchio, L., Guzmán, M., et al. (2017) · Neuron · doi:10.1016/j.neuron.2017.11.012 · Cited by 108 · see citing works
Endocannabinoid modulation of homeostatic and non-homeostatic feeding circuits
Lau, B. K., Cota, D., Cristino, L., & Borgland, S. L. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.05.033 · Cited by 102 · see citing works
Endocannabinoid dynamics gate spike-timing dependent depression and potentiation
Cui, Y.-H., Prokin, I., Xu, H., Delord, B., Genet, S., Venance, L., & Berry, H. (2016) · eLife · doi:10.7554/elife.13185 · Cited by 60 · see citing works
Endocannabinoid–Dopamine Interactions in Striatal Synaptic Plasticity
Mathur, B. N., & Lovinger, D. M. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00066 · Cited by 74 · see citing works
“Maintained expression of eCB-LTD may require adenylyl cyclase inhibition and decreased production of cAMP, resulting in a decrease in the probability of glutamate release (Heifets et al., 2008; Mato et al., 2008).”
BackgroundL-type voltage-dependent Ca2+ channels mediate expression of presynaptic LTP in amygdala
Fourcaudot, E., Gambino, F., Casassus, G., Poulain, B., Humeau, Y., & Lüthi, A. (2009) · Nature Neuroscience · doi:10.1038/nn.2378 · Cited by 69 · see citing works
Molecular and cellular mechanisms of dopamine-mediated behavioral plasticity in the striatum
Cerovic, M., d’Isa, R., Tonini, R., & Brambilla, R. (2013) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2013.06.013 · Cited by 66 · see citing works
Pan, B., Zhong, P., Sun, D., & Liu, Q.-S. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.1040-11.2011 · Cited by 59 · see citing works
“We and others have shown that cAMP/PKA signaling is required for eCBdependent LTD/I-LTD (Chevaleyre et al., 2007; Mato et al., 2008; Pan et al., 2008b; Chiu et al., 2010).”
BackgroundMechanisms of endocannabinoid control of synaptic plasticity
Winters, B. L., & Vaughan, C. W. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108736 · Cited by 63 · see citing works
Martinez, A. A., Macheda, T., Morgese, M. G., Trabace, L., & Giuffrida, A. (2011) · Neuroscience Research · doi:10.1016/j.neures.2011.12.006 · Cited by 56 · see citing works
“…striatal neurotransmission via a PKA-dependent mechanism affecting the exocytosis of synaptic vesicles (Seino and Shibasaki 2005) and/or endocannabinoid-mediated plasticity at excitatory and inhibitory synapses (Chevaleyre et al. 2007; Heifets et al. 2008; Mato et al. 2008; Pan et al. 2008).”
Mechanisms of Endocannabinoid Transport in the Brain
Kaczocha, M., & Haj-Dahmane, S. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15469 · Cited by 39 · see citing works
“The expression of endocannabinoid-LTD is predominantly mediated by Gi/o-dependent inhibition of the adenylate cyclase/cAMP/PKA signal- ling pathway (Chevaleyre et al., 2006; Haj-Dahmane & Shen, 2010; Hei- fets & Castillo, 2009) and may involve functional alteration of the presynaptic proteins Rab3B/RIM1a (Chevaleyre e…”
BackgroundInfluentialDrug-Induced Alterations of Endocannabinoid-Mediated Plasticity in Brain Reward Regions
Zlebnik, N. E., & Cheer, J. F. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.1712-16.2016 · Cited by 55 · see citing works
“…DSI/DSE, eCB-LTD involves downregulation of the cAMP/PKA pathway, and this generates long-term interference with neurotransmitter release machinery (Lonart et al., 2003; Chevaleyre et al., 2007) and calcium influx via voltagegated calcium channels (Robbe et al., 2002; Mato et al., 2005, 2008).”
BackgroundWu, H.-F., Lu, T.-Y., Chu, M.-C., Chen, P. S., Lee, C. J., & Lin, H. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107736 · Cited by 45 · see citing works
Park, H.-Y., Rhee, J., Lee, S., & Chung, C. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.06.049 · Cited by 43 · see citing works
Lovelace, J. W., Corches, A., Vieira, P. A., Hiroto, A. S., Mackie, K., & Korzus, E. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.04.034 · Cited by 43 · see citing works
“Both CB1R and mGluR2/3 depend on the activity of G-proteincoupled receptors (GPCRs), and they share the same intracellular G/o pathways and have been shown to actually occlude one another in some cases and to compensate for one another in other cases (Mato et al., 2008; Mato et al., 2005).”
BackgroundManz, K. M., Baxley, A. G., Zurawski, Z., Hamm, H. E., & Grueter, B. A. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.1395-19.2019 · Cited by 38 · see citing works
“Presynaptically-expressed mGluRs in the NAc have previously been shown to decrease vesicular release by selectively targeting P/Q-type VGCCs (Robbe et al., 2002; Mato et al., 2008).”
BackgroundThe endocannabinoid system in the amygdala and modulation of fear
Gunduz‐Cinar, O. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110116 · Cited by 38 · see citing works
Qian, W., Yin, N., Gao, F., Miao, Y., Li, Q., Li, F., Sun, X., Yang, X., & Wang, Z. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.04.027 · Cited by 37 · see citing works
“…couple to various intracellular signaling pathways, such as forskolin-stimulated cAMP/protein kinase A (PKA) signaling pathway (Hoddah et al., 2009; Mato et al., 2008; Martinez et al., 2012; Wang et al., 2012), mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) and…”
BackgroundJoffe, M. E., Centanni, S. W., Jaramillo, A. A., Winder, D. G., & Conn, P. J. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00200 · Cited by 36 · see citing works
Lau, B. K., Ambrose, B. P., Thomas, C. S., Qiao, M., & Borgland, S. L. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.2049-19.2020 · Cited by 27 · see citing works
Kind, L., & Kursula, P. (2018) · Amino Acids · doi:10.1007/s00726-018-2682-8 · Cited by 26 · see citing works
Neurobiologia da Cannabis: do sistema endocanabinoide aos transtornos por uso de Cannabis
Costa, J., Maia, L. O., Orlandi-Mattos, P., Villares, J., & Esteves, M. A. F. (2011) · Jornal Brasileiro de Psiquiatria · doi:10.1590/s0047-20852011000200006 · Cited by 6 · see citing works
New insights on endocannabinoid transmission in psychomotor disorders
Giuffrida, A., & Seillier, A. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.04.002 · Cited by 21 · see citing works
“…actions, including: 1) normalization of aberrant neurotransmission and synaptic plasticity (Chevaleyre et al., 2007; Kreitzer and Malenka, 2007; Mato et al., 2008; Morgese et al., 2009; Picconi et al., 2003); and 2) inhibition of levodopa-induced activation of cAMP/DARPP32 signaling, which is…”
Kang, S. J., Liu, M., Shi, T., Zhao, M., Kaang, B., & Zhuo, M. (2013) · Molecular Pain · doi:10.1186/1744-8069-9-58 · Cited by 18 · see citing works
“The possibility of low doses of the drugs causing the negative results is unlikely, because the drug concentrations used in the present experiment are not lower compared to other studies [4,10,49].”
BackgroundResultFontaine, C. J., Gräfe, E. L., Pinar, C., Río, I. B., Grandes, P., & Christie, B. R. (2020) · Learning & Memory · doi:10.1101/lm.050666.119 · Cited by 19 · see citing works
“The CB1R is coupled to Gi/o and leads to a suppression of neurotransmitter release from the presynaptic terminal (Wilson et al. 2001; Wilson and Nicoll 2002b; Chevaleyre et al. 2006; Mato et al. 2008; Katona and Freund 2012).”
BackgroundImaging the endocannabinoid signaling system
Dudok, B., & Soltész, I. (2021) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2021.109451 · Cited by 18 · see citing works
Insulin and endocannabinoids in the mesolimbic system
Sallam, N. A., & Borgland, S. L. (2021) · Journal of Neuroendocrinology · doi:10.1111/jne.12965 · Cited by 15 · see citing works
Muñoz, B., Fritz, B. M., Yin, F., & Atwood, B. K. (2022) · The Journal of Physiology · doi:10.1113/jp283513 · Cited by 5 · see citing works
“…to the mechanism of induction of the inhibition of glutamate of CB1 or eCB-LTD in that it involves cAMP-PKA-protein translation signaling and both occur at AIC-DLS synapses (Lonart et al., 2003; Yin et al., 2006; Mato et al., 2008; Yasuda et al., 2008; Atwood et al., 2014b; Younts et al., 2016).”
BackgroundEndocannabinoids and Dopamine Balance Basal Ganglia Output
Gorodetski, L., Loewenstern, Y., Faynveitz, A., Bar‐Gad, I., Blackwell, K. T., & Korngreen, A. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.639082 · Cited by 3 · see citing works
“…reported in several brain regions such as the dorsal striatum (Kreitzer and Malenka, 2007, 2005; Ronesi and Lovinger, 2005; Wang et al., 2006), NAc (Mato et al., 2008; Robbe et al., 2002), the cortex (Lafourcade et al., 2007; Nevian and Sakmann, 2006; Panikashvili et al., 2005), the cerebellum…”
BackgroundActomyosin-mediated inhibition of synaptic vesicle release under CB1R activation
McFadden, M. H., Emeritt, M.-B., Xu, H., Cui, Y., Leterrier, C., Zala, D., Venance, L., & Lenkei, Z. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03017-4 · Cited by 3 · see citing works
Characterization of excitatory synaptic transmission in the retrosplenial cortex of adult mice
Wan, J., Ma, Y., Chen, X., Tao, W., Hao, S., Geng, W., Wu, Y., & Zhuo, M. (2025) · Molecular Pain · doi:10.1177/17448069251335500 · Cited by 2 · see citing works
“19,28,48,49 A possible explanation for this is that other VGCCs may perform some other function than mediating excitatory synaptic transmission.”
Endocannabinoid-Dependent Synaptic Plasticity in the Striatum
Atwood, B. K., & Lovinger, D. M. (2017) · Springer eBooks · doi:10.1007/978-3-319-57371-7_5 · Cited by 2 · see citing works
Muñoz, B., Fritz, B. M., Yin, F., & Atwood, B. K. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.31.458358 · Cited by 2 · see citing works
Chao, D., Liu, Y., Cheng, T., Hogan, Q. H., & Pan, B. (2025) · Journal of Neurophysiology · doi:10.1152/jn.00379.2025 · Cited by 1 · see citing works
VTA GABAergic Plasticity: An Inhibitory Synaptic Model of Drug Addiction
Nugent, F. S. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6978-1_5 · Cited by 1 · see citing works
Threlfell, S., & West, A. R. (2014) · Wiley eBooks · doi:10.1002/9781118836507.ch11 · Cited by 1 · see citing works
Cannabinoid receptor function in the medial prefrontal cortex
den Boon, F. S. (2013) · UvA-DARE (University of Amsterdam)
Changes in the Endocannabinoid system in the Brain Following Bilateral Vestibular Damage
Baek, J. (2011) · Otago University Research Archive (University of Otago)
Muñoz, B., Fritz, B. M., & Attwood, B. (2024) · doi:10.22541/au.170667781.18367712/v1
Endocannabinoid regulation of cortical functions
Dudok, B. (2025) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-443-13908-6.00012-8
Khlaifia, A. (2015) · theses.fr (ABES) · doi:10.70675/48826ff3zef5bz49d0z8389z57ab7666f35b
Socio-communicative and nucleus accumbens core dysfunctions in fragile X syndrome
Giua, G. (2023) · theses.fr (ABES) · doi:10.70675/e45d048ez2538z4905zba74z1de16201406a
Schizophrenia and Endocannabinoid Signaling in the Prefrontal Cortex
Lovelace, J. W. (2014) · eScholarship (California Digital Library)
- Authors
- Mato, S., Lafourcade, M., Robbe, D., Bakiri, Y., & Manzoni, O. J.
- Affiliations
- Inserm (FR)
- Corresponding author
- Manzoni, Olivier J.
- Venue
- Neuropharmacology
- Publisher
- Elsevier BV
- Published
- 2008-01
- Volume
- 54
- Issue
- 1
- Pages
- 87-94
- ISSN
- 0028-3908 (ISSN-L)
- OpenAlex
- W2064665634
- Cited by
- 62
- References
- 43
- Citations by year
- 2025: 3 · 2024: 2 · 2023: 1 · 2022: 1 · 2021: 6 · 2020: 3 · 2019: 3 · 2018: 3 · 2017: 6 · 2016: 3 · 2015: 2 · 2014: 4 · 2013: 5 · 2012: 4
- FWCI
- 1.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuropharmacology (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology › Cannabis and Cannabinoid Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- nucleus accumbens, P/Q-type calcium channels, adenylate cyclase, presynaptic inhibition, glutamatergic neurotransmission, prefrontal cortex, CB1 receptor, omega-agatoxin IVA, synaptic plasticity, addiction
- MeSH terms
- Action Potentials, Cyclic AMP, Animals, Calcium, Calcium Channel Blockers, Carbazoles, Chlorides, Electric Stimulation, Enzyme Inhibitors, Colforsin, Indoles, Male, Mice, Inbred C57BL, Nucleus Accumbens, Pyrroles, Signal Transduction, 4-Aminopyridine, Barium Compounds, Patch-Clamp Techniques, Calcium Channels, P-Type, Potassium Channel Blockers, Long-Term Synaptic Depression, Mice, Cannabinoid Receptor Modulators, Endocannabinoids, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review